Your browser doesn't support javascript.
loading
Pilot Study in Temporary Peripheral Nerve Stimulation in Oncologic Pain.
Mainkar, Ojas; Solla, Che Antonio; Chen, Grant; Legler, Aron; Gulati, Amitabh.
Affiliation
  • Mainkar O; Department of Anesthesiology, New York Presbyterian Hospital, New York, NY, USA.
  • Solla CA; Pain Medicine Associates, Johnson City, TN, USA.
  • Chen G; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Legler A; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Gulati A; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Neuromodulation ; 23(6): 819-826, 2020 08.
Article in En | MEDLINE | ID: mdl-32185844
ABSTRACT

OBJECTIVES:

Temporary, percutaneous peripheral nerve stimulation (PNS) has been shown to provide analgesia for acute postoperative pain, postamputation pain, and low back pain. The implanted device stimulates the neural target for up to 60 days at which point the leads are extracted. Patients have demonstrated prolonged analgesia continuing after extraction of the leads. The purpose of this case series is to demonstrate peripheral neural targets that could feasibly be used to treat various pain syndromes prevalent in the oncologic population. MATERIALS AND

METHODS:

A temporary, percutaneous PNS was implanted under ultrasound guidance in 12 oncologic chronic pain patients seen in an outpatient pain clinic who had failed medical and/or interventional management. The device was implanted for up to 60 days. Clinical progress of pain and functional capacity was monitored through regular clinical visits.

RESULTS:

The case series presents seven successful cases of implementation of the PNS to treat oncologic pain. Three of these cases demonstrate targeting of proximal spinal nerves to treat truncal neuropathic pain and lumbar radicular pain. The four remaining cases demonstrate successful targeting of other peripheral nerves and brachial plexus. We also share five failed cases without adequate pain relief with PNS.

CONCLUSIONS:

PNS has potential uses in the treatment of oncologic pain. Further high-quality studies should be designed to further elucidate use of the PNS to treat oncologic pain.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peripheral Nerves / Transcutaneous Electric Nerve Stimulation / Cancer Pain / Neuralgia Type of study: Guideline Limits: Humans Language: En Journal: Neuromodulation Year: 2020 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peripheral Nerves / Transcutaneous Electric Nerve Stimulation / Cancer Pain / Neuralgia Type of study: Guideline Limits: Humans Language: En Journal: Neuromodulation Year: 2020 Document type: Article Affiliation country: United States